On July 24, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 21, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 20, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 11-20 the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The FDA should push back its deadline for implementation of new cosmetics facility registration requirements of the Modernization of Cosmetics Regulation Act of 2022, the National Customs Brokers & Forwarders Association of America said in a July 13 letter.
FDA will continue its policy of not requiring on-site audits for importers under the agency’s preventive controls and Foreign Supplier Verification Program regulations where COVID-19 travel advisories make them impractical until further notice, despite the recent end to the government’s public health emergency in May, the agency said in a revised guidance document released July 13.
On July 10, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 7, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 5, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 3, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: